Identification of KasA as the cellular target of an anti-tubercular scaffold-Reference-Cited by-同舟云学术

Identification of KasA as the cellular target of an anti-tubercular scaffold

Published:2016-09-01 Issue:1 Volume:7 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Abrahams Katherine A.,Chung Chun-wa,Ghidelli-Disse Sonja,Rullas Joaquín,Rebollo-López María José,Gurcha Sudagar S.,Cox Jonathan A. G.,Mendoza Alfonso,Jiménez-Navarro Elena,Martínez-Martínez María Santos,Neu Margarete,Shillings Anthony,Homes Paul,Argyrou Argyrides^ORCID,Casanueva Ruth,Loman Nicholas J.,Moynihan Patrick J.,Lelièvre Joël,Selenski Carolyn,Axtman Matthew,Kremer Laurent,Bantscheff Marcus^ORCID,Angulo-Barturen Iñigo,Izquierdo Mónica Cacho,Cammack Nicholas C.,Drewes Gerard,Ballell Lluis,Barros David,Besra Gurdyal S.,Bates Robert H.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms12581.pdf

Reference55 articles.

1. Kaufmann, S. H. & van Embden, J. D. Tuberculosis: a neglected disease strikes back. Trends Microbiol. 1, 2–5 (1993).

2. Zumla, A., Nahid, P. & Cole, S. T. Advances in the development of new tuberculosis drugs and treatment regimens. Nat. Rev. Drug Discov. 12, 388–404 (2013).

3. World Health Organisation. Global Tuberculosis Report WHO (2014).

4. Ballell, L. et al. Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis. ChemMedChem. 8, 313–321 (2013).

5. Rebollo-Lopez, M. J. et al. Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery. PLoS ONE 10, e0142293 (2015).

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating computational and experimental approaches in discovery and validation of MmpL3 pore domain inhibitors for specific labelling of Mycobacterium tuberculosis;International Journal of Biological Macromolecules;2024-11

2. The Mycobacterium tuberculosis Cell Wall: An Alluring Drug Target for Developing Newer Anti‐TB Drugs—A Perspective;Chemical Biology & Drug Design;2024-09

3. Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies;International Journal of Biological Macromolecules;2024-08

4. Azetidines Kill Multidrug-Resistant Mycobacterium tuberculosis without Detectable Resistance by Blocking Mycolate Assembly;Journal of Medicinal Chemistry;2024-02-08

5. Virtual screening and identification of promising therapeutic compounds against drug-resistant Mycobacterium tuberculosis β-ketoacyl-acyl carrier protein synthase I (KasA);Journal of Biomolecular Structure and Dynamics;2023-12-13